PLASTIC AND RECONSTRUCTIVE SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-04-23 张思思

外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表:
这个杂志效率有点慢，投搞了20天了，一直with editor

Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor

417 10 举报

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2025-05-29 ms3000001735198901 来自吉隆坡

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：整形;乳腺;重建
经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态

10 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-07-18 changfusun 来自辽宁省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：比较不易，创新性必须强

208 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-07-05 糖葫芦好吃

想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例
另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破

408 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2013-06-07 whiteorchidfay

审稿速度:2.0 | 投稿命中率:25.0
经验分享：目前中稿两篇，二审一篇，总共投过五篇。

现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。

632 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-11-16 伟大理想

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：手指再造;创面修复
经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右

213 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-01-21 Atropine1470

这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表:
投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm

gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm

448 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-07-18 ms4000001022772560

偏重的研究方向：整形外科
经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件

246 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-28 MS54455111222

什么时候使用柱状图，什么时候使用折线图？

325 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=589543, encodeId=05465895433d, content=外审的话status会变吗？一直是with editorAtropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, beContent=Atropine 2020-01-21 00:00:00 发表: 这个杂志效率有点慢，投搞了20天了，一直with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyD2E2FSTJzINAc4Pyas8XKbVr2He8AT0a5ShkdfbCVnaBERzHqoq9ZQCwvQXu5gPfSQmrjAPRQg/132, createdBy=088a2443910, createdName=张思思, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267146, encodeId=ecf4226e14667, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：整形;乳腺;重建 经验分享：请问这个杂志稿件提交后是必须每个作者点了同意才会审稿吗，提交了10天了还是Submitted to Journal的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu May 29 11:48:18 CST 2025, time=2025-05-29, status=1, ipAttribution=吉隆坡), GetPortalCommentsPageByObjectIdResponse(id=2148654, encodeId=c8a521486546e, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：比较不易，创新性必须强, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3eb4697116, createdName=changfusun, createdTime=Tue Jul 18 19:49:35 CST 2023, time=2023-07-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=801288, encodeId=8c6a80128820, content=想投一篇case 问一下大家投稿经验，可以并列一作吗？毕竟是多学科合作的病例 另外我看投稿要求是case图加表只能有4个，我们有好多图，这怎么破, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2db01701309, createdName=糖葫芦好吃, createdTime=Sun Jul 05 10:24:50 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496151, encodeId=193c49615114, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：目前中稿两篇，二审一篇，总共投过五篇。 现在审稿速度是越来越快了，两三周可以外审回来，但是不是那么好中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=632, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67e282761, createdName=whiteorchidfay, createdTime=Fri Jun 07 03:19:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100924, encodeId=61e42100924a3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：手指再造;创面修复 经验分享：总得来说，一审很快，审稿意见很专业，编辑很负责。临床术式如果有配图会更容易接收，不足之处在于后续返修-二审-三审的时间比较长，从投稿到接收来来回回需要半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ab55496562, createdName=伟大理想, createdTime=Wed Nov 16 17:55:25 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583679, encodeId=dc985836e997, content=这个杂志效率有点慢，投搞了20天了，一直with editorgywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, beContent=gywdoctor 2019-08-19 20:46:00 发表: 投稿要求：http://edmgr.ovid.com/prs/accounts/ifauth.htm, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233150, encodeId=763a123315043, content=偏重的研究方向：整形外科 经验分享：投稿半个月，显示提交状态，还没有分配编辑，是因为作者没有完全确认吗？有一个作者换了好几个邮箱都收不到确认邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc28218533, createdName=ms4000001022772560, createdTime=Mon Jul 18 11:16:30 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097162, encodeId=466c109e1624c, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097161, encodeId=ce9b109e1617d, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 衣谷

为什么期刊要求用三线表/使用三线表的意义何在？

309 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务